Results 181 to 190 of about 142,808 (332)

Analgesic Efficacy of Low‐Level Laser Therapy for Postoperative Endodontic Pain: A Systematic Review and Meta‐Analysis

Australian Endodontic Journal, EarlyView.
ABSTRACT This systematic review analysed the analgesic efficacy of low‐level laser therapy (LLLT) compared to conventional drug therapy and placebo for postoperative pain in endodontics. PubMed, PubMed Central, Scopus, LILACS, SciELO, Virtual Health Library, Embase and Open Gray were searched.
Gabriela Bonacina, Rafael Chies Hartmann, Maximiliano Schünke Gomes, Daiana Elisabeth Böttcher   +3 more
wiley   +1 more source

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Use Is Associated With an Increased Risk of Femoral Osteonecrosis in Migraine Patients: A Retrospective, TriNetX Database-Based Study. [PDF]

Cureus
Bisiani J, Matos F, Lynch B.
europepmc   +1 more source

Managing Skin Side Effects Associated With Oncology Treatments: Asian Perspective on Use of Dermocosmetics

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Skin adverse events (AEs) frequently accompany all types of anticancer treatments. This publication discusses how recent international guidance on best‐practices use of dermocosmetics can be adapted to the North Asia region (China, Hong Kong, Japan, Republic of Korea, and Taiwan).
Meng Pan, Jianguo Sun, Makoto Kawashima, You Chan Kim, Mison Chun, Chia‐Yu Chu, Yi‐Hsin Liang, Mee Chang, Delphine Kerob, Brigitte Dreno   +9 more
wiley   +1 more source

Cystoid Macular Edema as Manifestation of Smoldering Multiple Myeloma: A Case Report. [PDF]

J Vitreoretin Dis
Pandiri S, Meshkin RS, Chaaya C, Dorsey HG, Hoyek S, Zekavat SM, Patel NA.   +6 more
europepmc   +1 more source

Nonsteroidal antiinflammatory agents. IV. Syntheses of pyridobenzoxepin, pyridobenzothiepin and their acetic acid derivatives.

, 1981
Hiroaki Tagawa, Shiro Kubo, Fumiyoshi Ishikawa   +2 more
openalex   +2 more sources

Nonsteroidal anti-inflammatory drugs for dysmenorrhoea.

Cochrane Database of Systematic Reviews, 2015
J. Marjoribanks, Reuben Olugbenga Ayeleke, C. Farquhar, M. Proctor   +3 more
semanticscholar   +1 more source

A Longitudinal Assessment of Endometriosis Patients Prescribed Cannabis‐Based Medicinal Products: A Case Series From the UK Medical Cannabis Registry

Australian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
ABSTRACT Background Although there is growing evidence supporting the use of cannabis‐based medicinal products (CBMPs) for the management of chronic pain, there is a paucity of data on their effect on endometriosis‐associated chronic pain. Aims This study aimed to perform an analysis of pain‐specific and general health‐related quality of life (HRQoL ...
Sara Getter, Simon Erridge, John Warner‐Levy, Evonne Clarke, Katy McLachlan, Ross Coomber, Shelley Barnes, Alia Darweish Medniuk, Rahul Guru, Wendy Holden, Mohammed Sajad, Robert Searle, Azfer Usmani, Sanjay Varma, James J. Rucker, Michael Platt, Mikael H. Sodergren   +16 more
wiley   +1 more source

Real-World Treatment Patterns in Patients with Metastatic Castration-Sensitive Prostate Cancer in Japan: A Retrospective Health Administrative Data Analysis. [PDF]

Adv Ther
Kawai T, Kiyonaga F, Shibata H, Tanaka Y, Saito A.   +4 more
europepmc   +1 more source

Nonsteroidal Anti-inflammatory Drug Use Reduces Risk of Adenocarcinomas of the Esophagus and Esophagogastric Junction in a Pooled Analysis

, 2020
Linda M. Liao, Thomas L. Vaughan, Douglas A. Corley, Michael B. Cook, Alan G. Casson, Farin Kamangar, Christian C. Abnet, Harvey A. Risch, Carol Giffen, Neal D. Freedman, Wong‐Ho Chow, Shahram Sadeghi, Nirmala Pandeya, David C. Whiteman, Liam Murray, Leslie Bernstein, Marilie D. Gammon, Anna H. Wu   +17 more
openalex   +1 more source

“Super‐Responders” to Dupilumab Treatment in Patients With Primary Diffuse Chronic Rhinosinusitis With Nasal Polyps

Allergy, EarlyView.
This study aimed to evaluate the feasibility of extending dupilumab dosing intervals in T2‐CRSwNP by assessing how many patients maintain disease control with once‐every‐12‐weeks (Q12W) dosing and comparing clinical characteristics of super‐responders and excellent responders. Tapering of dupilumab to Q12W appears feasible in super‐responding patients.
P. E. Vonk, J. J. Otten, H. B. E. Elzinga, R. J. L. van der Lans, G. F. J. P. Adriaensen, L. B. L. Benoist, D. R. Hoven, W. J. Fokkens, S. Reitsma, PolyREG Consortium, A.B. Rinia, I. Krebbers, I.J. Kleiss, M. E. Cornet   +13 more
wiley   +1 more source